The Qatar Cancer Society (QCS) and GlaxoSmithKline (GSK) launched a nationwide cervical cancer awareness campaign in an effort to educate women in Qatar about the disease. The new ‘Think Again’ campaign aims to dispel myths and misconceptions that currently surround cervical cancer and help women to make well-informed decisions about their health.
While many women continue to underestimate their risk of getting cervical disease, it can be a threat to all women, with one woman being diagnosed with cervical cancer every minute and a woman dying from the disease every two globally. The Middle East loses one woman every hour to cervical cancer.
Research shows that early vaccination against cervical cancer between the ages of 13 to 25 is the most effective means of preventing the disease. Alongside regular screening, vaccination could reduce the risk of cervical cancer by up to 93%. The vaccination consists of three shots and will be effective for life.
Commenting on the new initiative, HE Sheikh Dr Khalid bin Jabor Al Thani, Chairman of QCS said:
This marks another step forward in our battle against cancer. Today, women around the State of Qatar will be able to learn more about cervical cancer and the best ways for prevention and early detection. We realise the importance of having a world-class partner such as GlaxoSmithKline to help us in executing this initiative.’
QCS officials stated that all women who are eligible for vaccination will be able to obtain it free of cost with 99% of the vaccine in the country supplied by GlaxoSmithKline. The launch of a new interactive website in the very near future will provide full details of the campaign and online registration.
Visit the GSK website about the ’Think again’ campaign and dedicated to cervical cancer information.
The Qatar Cancer Society operates solely through donations from supporters. For more information, please visit their website.